Free tool
Diagnostics stocks
We cover 31 companies grouped under the Diagnostics theme. The median market value in the group is $1.26B. Across the group, the median move over the past trading day is −0.68%. 71% of the 31 with a 200-day average trade above it. Price change over the past year runs from −30.1% to +145.3% across the middle 80 percent of the group, with a median of −5.3%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
31 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| QGEN | Qiagen N.V. | $9.01B | Mid cap | −9.65% | Nov 4, 2026 |
| QIA.DE | Qiagen N.V. | $8.99B | Mid cap | −6.73% | Nov 4, 2026 |
| CAI | Caris Life Sciences, Inc. | $7.58B | Mid cap | −29.83% | Nov 4, 2026 |
| 6869.T | Sysmex Corporation | $7.28B | Mid cap | +3.66% | Nov 4, 2026 |
| BLLN | BillionToOne, Inc. | $4.54B | Mid cap | −11.68% | Nov 5, 2026 |
| ADPT | Adaptive Biotechnologies Corporation | $4.18B | Mid cap | +101.70% | Nov 4, 2026 |
| VCYT | Veracyte, Inc. Common Stock | $3.56B | Mid cap | +54.81% | Nov 3, 2026 |
| GRAL | GRAIL, Inc. | $3.55B | Mid cap | +136.66% | Nov 11, 2026 |
| WGS | GeneDx Holdings Corp. | $2.69B | Mid cap | −30.11% | Oct 27, 2026 |
| CDNA | CareDx, Inc. | $2.64B | Mid cap | +283.45% | Nov 3, 2026 |
| NEOG | Neogen Corporation | $2.54B | Mid cap | +103.83% | Oct 8, 2026 |
| NEO | NeoGenomics, Inc. | $2.26B | Mid cap | +145.34% | Oct 27, 2026 |
| ALIF-B.ST | AddLife AB (publ) | $2.08B | Mid cap | −7.20% | Oct 21, 2026 |
| PSNL | Personalis, Inc. | $1.82B | Small cap | +257.32% | Nov 3, 2026 |
| DIA.WA | Diagnostyka S.A. | $1.54B | Small cap | −17.76% | Sep 10, 2026 |
| 4544.T | H.U. Group Holdings, Inc. | $1.26B | Small cap | +2.77% | Nov 11, 2026 |
| OPK | OPKO Health, Inc. | $1.11B | Small cap | +6.34% | Oct 28, 2026 |
| CSTL | Castle Biosciences, Inc. | $1.04B | Small cap | +52.96% | Nov 2, 2026 |
| QDEL | QuidelOrtho Corporation | $1.02B | Small cap | −46.31% | Nov 5, 2026 |
| 4694.T | BML, Inc. | $851.50M | Small cap | +5.42% | Nov 6, 2026 |
| FLGT | Fulgent Genetics, Inc. | $545.08M | Small cap | −8.46% | Nov 6, 2026 |
| CEVI.ST | CellaVision AB (publ) | $410.67M | Small cap | −5.28% | Oct 28, 2026 |
| NIOX.L | NIOX Group Plc | $392.35M | Small cap | −9.49% | Sep 29, 2026 |
| SBS.DE | Stratec SE | $322.43M | Small cap | −16.91% | Nov 12, 2026 |
| MYGN | Myriad Genetics, Inc. | $298.43M | Small cap | −47.39% | Nov 2, 2026 |
| BDSX | Biodesix, Inc. | $296.22M | Small cap | +225.53% | Nov 3, 2026 |
| OSUR | OraSure Technologies, Inc. | $255.87M | Small cap | +11.08% | Nov 4, 2026 |
| XGN | Exagen Inc. | $185.81M | Small cap | −19.69% | Nov 10, 2026 |
| LUCD | Lucid Diagnostics Inc. | $185.35M | Small cap | −22.96% | Nov 11, 2026 |
| IMDX | Insight Molecular Diagnostics Inc. | $145.30M | Small cap | +73.39% | Nov 9, 2026 |
| DVYSR.ST | Devyser Diagnostics AB (publ) | $105.23M | Small cap | −60.78% | Nov 3, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.